Mon. May 25th, 2026
Spread the love

When the Miami Dolphins extended quarterback Tua Tagovailoa in 2024, it was part of a much larger trend of QBs getting paid that offseason. With the rapidly rising price, teams were incentivized to get a deal done before the next domino fell somewhere else and raised the price again. The Dolphins secured Tua for the long term with a four-year, $212 million contract but as with all NFL deals, the devil is in the details.

Tagovailoa’s contract wasn’t as strong at signing as the rest of the deals that summer. Only $93.17 million was fully guaranteed at signing and that was his 2024 and 2025 compensation. Two years fully guaranteed is on the low end of the scale for a franchise player.

But in March of 2025, $54 million more became fully guaranteed for the 2026 season. That’s because the Dolphins used a rolling guarantee structure, which guarantees a future year, that essentially keeps turning the deal into a two-year commitment each offseason. As we sit here in September 2025, Miami is on the hook for a combined $106 million over the course of the 2025 and 2026 seasons.

In March 2026, the Dolphins will have another decision to make on Tagovailoa’s contract, but it’s a lower price point — just $3 million of his 2027 salary fully guarantees. Peanuts.

How can the Dolphins get out of the Tua Tagovailoa contract?

The only way the Miami Dolphins can get out of Tua Tagovailoa’s contract is by trading him. Otherwise they’re going to pay the whole sum in 2025 and 2026. So they need to convince another team to pay $55 million in 2026 cash to a guy the Dolphins don’t want on their team anymore. Seems unlikely.

If they release Tagovailoa, they will still owe him $55 million for 2026 minus whatever another team pays him.

Russell Wilson is the test case for Tua Tagovailoa — sort of

When the Denver Broncos traded for Russell Wilson in 2022, they gave him a massive contract extension. His 2022, 2023, and 2024 salaries were all fully guaranteed, but his 2025 compensation would become fully guaranteed in March of 2024.

In order to avoid that, the Broncos released him in March 2024 despite having to pay him $39 million for the 2024 season. That kept his 2025 salary of $37 million off Denver’s books.

The Dolphins could have done that early in the 2025 offseason, releasing Tagovailoa before the 2025 salary came due. But they didn’t, and now they are on the hook in a way the Broncos were not.

Kirk Cousins is the more accurate test case for Tua Tagovailoa

When the Atlanta Falcons signed Kirk Cousins in 2024, they gave him two years guaranteed on his four-year contract. Then they drafted Michael Penix, who they inserted into the lineup during the 2024 season. They didn’t need Cousins and his bloated salary anymore in 2025, but his salary was already fully guaranteed. They’d need to find a trade partner to make offloading him worth it.

At $27.5 million in salary plus a $10 million guaranteed bonus in 2026, no team pulled the trigger on a Cousins trade during the 2025 offseason. Now he’s the most expensive backup QB in NFL history. They were going to have to pay him anyway, so no use in releasing him.

Tagovailoa’s $55 million is nearly $20 million higher than the combined $37.5 million Cousins had coming. The Dolphins will only add $3 million in future guaranteed money for Tagovailoa if the keep him into the 2026 season. Like Cousins, there won’t be much of a financial benefit to moving on from Tua next year, so even if the Dolphins don’t want him as their 2026 starter, he could stay on the team the same way Cousins has in Atlanta.

You missed

From Tramadol to Canadian to Exol-5 The New Drug Destroying Nigerian Youths An Investigative Article .From Tramadol to Canadian to Exol-5: The New Drug Destroying Nigerian Youths An Investigative Report on the Shifting Landscape of Substance Abuse in Nigeria Nigeria faces a severe and evolving drug crisis, particularly among its youth. What began with the widespread abuse of Tramadol has progressed through mixtures like “Canadian” to newer pharmaceutical diversions such as Exol-5. This shift reflects deeper issues: easy access to prescription drugs, weak regulation, socioeconomic pressures, and aggressive street-level marketing. NDLEA operations and health studies reveal a public health emergency that threatens an entire generation. Phase 1: The Tramadol Epidemic (2010s–Early 2020s) Tramadol, a synthetic opioid prescribed for moderate to severe pain, became Nigeria’s most notorious street drug. Cheap, potent, and widely smuggled (often from India and other Asian countries), it offered users energy, euphoria, and pain relief — appealing to commercial drivers, laborers, students, and young men seeking confidence or stamina. Scale of the Problem: Millions of tablets seized annually by NDLEA. High prevalence among young males aged 15–35. Linked to increased crime, sexual violence, organ damage (kidney failure, seizures), and mental health breakdowns. Contributed to broader opioid misuse alongside codeine cough syrups. Government responses included tighter import controls and public awareness campaigns, but these only displaced demand to other substances rather than eliminating it. Phase 2: The Rise of “Canadian” (Mid-2020s) “Canadian” or “Canadian Loud” emerged as a popular code for high-grade cannabis (often indica-dominant strains) or cannabis mixed with other synthetics. It gained traction as users sought alternatives or combinations to Tramadol’s effects. This phase marked a move toward imported or locally cultivated premium weed, sometimes laced with stronger chemicals. Youths in urban centers like Lagos, Kano, Jos, and Onitsha embraced it for its perceived “cleaner” high compared to opioids. However, it fueled polydrug use — combining cannabis with opioids, sedatives, or alcohol — amplifying health risks. Phase 3: Exol-5 – The Current Threat (2024–2026) Exol-5 (Benzhexol Hydrochloride / Trihexyphenidyl 5mg), originally a prescription medication for Parkinson’s disease and drug-induced movement disorders, has become the latest pharmaceutical being heavily abused. Why Exol-5? Euphoric Effects: Users report intense euphoria, hallucinations, and a sense of detachment — making it attractive as a cheap “upper” or escape. Accessibility: Sold over-the-counter or on the black market despite being a controlled prescription drug. NDLEA has seized millions of pills in single operations (e.g., 3.1 million pills in Kano in late 2024, and over 5.6 million combined with Tramadol in other busts). Street Names: Exol, Artane, Benzhexol, “Farin Mallam” (in Northern Nigeria). Demographics: Prevalent among youths, laborers, and even psychiatric patients who divert prescriptions. Studies show abuse rates as high as 25% among certain outpatient groups. Health Consequences: Anticholinergic toxicity: Confusion, dry mouth, blurred vision, urinary retention, constipation, and in high doses — delirium, psychosis, seizures, and heart issues. Long-term: Cognitive impairment, addiction, exacerbated mental health disorders. Often mixed with Tramadol, codeine, or cannabis, creating dangerous synergies. In cities like Jos, Exol-5 sits alongside diazepam, Rohypnol, and Tramadol on street markets, easily available to teenagers and young adults. Why This Evolution Continues Supply-Side Failures: Porous borders, corrupt officials, and overproduction of pharmaceuticals enable diversion. Demand Drivers: Unemployment, poverty, peer pressure, trauma, and the pursuit of performance enhancement (e.g., for “hustle” culture). Weak Regulation: Many pharmacies sell restricted drugs without prescriptions. Online and street vendors fill gaps. Displacement Effect: Cracking down on one substance (Tramadol/codeine) pushes users and dealers toward the next available option. NDLEA reports ongoing large seizures, but the problem persists due to high profitability and low risk for mid-level distributors. Broader Impacts on Nigerian Youths Education: Increased dropout rates and poor academic performance. Mental Health: Rising cases of psychosis and depression. Economy: Lost productivity among the working-age population. Crime and Violence: Drug-fueled robberies, cultism, and family breakdowns. Public Health System Strain: Overburdened hospitals treating overdoses and chronic complications. Young people aged 15–39 remain the hardest hit, with national surveys showing drug use prevalence significantly above global averages. What Must Be Done Stronger Enforcement: Consistent prosecution of corrupt enablers and large-scale traffickers. Regulation: Crackdown on rogue pharmacies and better tracking of prescription drugs. Prevention & Rehabilitation: School programs, community outreach, and expanded treatment centers (currently woefully inadequate). Economic Alternatives: Address root causes like youth unemployment. Public Awareness: Honest campaigns highlighting real dangers of “Exol-5” and similar drugs. Conclusion From Tramadol’s opioid grip to “Canadian” cannabis culture and now Exol-5’s anticholinergic highs, Nigeria’s drug crisis is mutating faster than responses can contain it. Exol-5 represents the dangerous new frontier — a legitimate medicine turned youth destroyer due to misuse and greed. Without urgent, multi-layered intervention — combining supply disruption, demand reduction, and socioeconomic support — an entire generation risks being lost to addiction. The time for half-measures is over. Nigeria’s future depends on winning this fight.